Evaluation of a novel serology algorithm to detect herpes simplex virus 1 or 2 antibodies

Sexually Transmitted Diseases

Volumn 37, Issue 11, 2010, Pages 696-699

  Zahariadis, George ^a,b   Severini, Alberto ^c,d  

^a PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ALGORITHM; ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; GOLD STANDARD; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOASSAY; SENSITIVITY AND SPECIFICITY; SEROLOGY; VIRUS DETECTION; WESTERN BLOTTING;

ALBERTA; ALGORITHMS; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOGLOBULIN G; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 78149281052     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181e2cdab     Document Type: Article

References (25)

1. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-1111.
2. Lafferty WE, Krofft S, Remington M, et al. Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population. J Clin Microbiol 1987;25:323-326.
3. Wald A, Zeh J, Barnum G, et al. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996;124(1 pt 1):8-15.
4. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000;342:844-850.
5. Wald A, Ashley-Morrow R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin Infect Dis 2002;35(suppl 2):S173-S182.
6. Canadian Guidelines on Sexually Transmitted Infections. 2008. Available at: http://www.phac-aspc.gc.ca/std-mts/sti-its/pdf/sti-its-eng.pdf.
7. Ratnam S, Severini A, Zahariadis G, et al. The diagnosis of genital herpes-Beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology. Can J Infect Dis Med Microbiol 2007;18:233-240.
8. Ashley RL. Sorting out the new HSV type specific antibody tests. Sex Transm Infect 2001;77:232-237.
9. Ashley RL. Performance and use of HSV type-specific serology test kits. Herpes 2002;9:38-45.
10. Song B, Dwyer DE, Mindel A. HSV type specific serology in sexual health clinics: Use, benefits, and who gets tested. Sex Transm Infect 2004;80:113-117.
11. Turner KR, Wong EH, Kent CK, et al. Serologic herpes testing in the real world: Validation of new type-specific serologic herpes simplex virus tests in a public health laboratory. Sex Transm Dis 2002;29:422-425.
12. Morrow RA, Friedrich D. Inaccuracy of certain commercial enzyme immunoassays in diagnosing genital infections with herpes simplex virus types 1 or 2. Am J Clin Pathol 2003;120:839-844.
13. Corey L. Challenges in genital herpes simplex virus management. J Infect Dis 2002;186(suppl 1):S29-S33. (Pubitemid 35178846)
14. Lafferty WE. The changing epidemiology of HSV-1 and HSV-2 and implications for serological testing. Herpes 2002;9:51-55.
15. Ashley RL, Militoni J. Use of densitometric analysis for interpreting HSV serologies based on Western blot. J Virol Methods 1987;18:159-168.
16. Lowry R. VassarStat: Web Site for Statistical Computation 1998-2006. http://faculty.vassar.edu/lowry/VassarStats.html.
17. Newcombe RG. Two-sided confidence intervals for the single proportion: Comparison of seven methods. Stat Med 1998;17:857-872.
18. Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927;22:209-212.
19. Leach CT, Ashley RL, Baillargeon J, et al. Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents. Clin Diagn Lab Immunol 2002;9:1124-1125.
20. Summerton J, Riedesel M, Laeyendecker O, et al. Effect of sexually transmitted disease (STD) coinfections on performance of three commercially available immunosorbent assays used for detection of herpes simplex virus type 2-specific antibody in men attending Baltimore, Maryland, STD clinics. Clin Vaccine Immunol 2007;14:1545-1549.
21. Ashley-Morrow R, Nollkamper J, Robinson NJ, et al. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 2004;10:530-536.
22. Hogrefe W, Su X, Song J, et al. Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition. J Clin Microbiol 2002;40:3635-3640.
23. van Dyck E, Buve A, Weiss HA, et al. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol 2004;42:2961-2965.
24. Laeyendecker O, Henson C, Gray RH, et al. Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans. J Clin Microbiol 2004;42:1794-1796.
25. Morrow R, Friedrich D. Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or-2 infection. Clin Microbiol Infect 2005;12:463-469.